Aethlon Medical (AEMD) Posts Smaller Q3 Loss

Aethlon Medical (NASDAQ: AEMD) reported Q3 EPS of ($0.28), $0.75 better than the analyst estimate of ($1.03). Revenue for the quarter came in at $413.5 thousand versus the consensus estimate of $190 thousand.

For earnings history and earnings-related data on Aethlon Medical (AEMD) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Corpay agrees to $100M FTC settlement over marketing practices
• UBS cuts KOSPI target by nearly 10% to reflect higher rates